Mutation Analysis in Chronic Myeloid Leukemia (CML)
0 Views
administrator
06/27/23
The panelists, Jorge Cortes, MD; Kevin Kelly, MD, PhD; Harry Erba, MD, PhD; Javier Pinilla-Ibarz, MD, PhD; and David Snyder, MD, FACP, explain technological advances in mutation analysis for chronic myeloid leukemia (CML).
-
Category
Show more
Facebook Comments
No comments found